Cross population validation of European GWAS-identified risk variants for multiple myeloma in a Pakistani cohort
Hematology, Transfusion and Cell Therapy · 2027-01 · 49 (1) · 108585
DOI: 10.1016/j.htct.2026.108585 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hematology, Transfusion and Cell Therapy, 2027-01. Verfasst von Wasif Mehmood und 11 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Mehmood, W., Shahzad, H., Mujtaba, M. A., Mohsin, M., Khan, M. A., Shamshad, G. U., Stein, A., Güler, M., Raja, G. K., Macauda, A., Canzian, F., & Saeed, S. (2027). Cross population validation of European GWAS-identified risk variants for multiple myeloma in a Pakistani cohort. Hematology, Transfusion and Cell Therapy, 49(1), 108585. https://doi.org/10.1016/j.htct.2026.108585
Vancouver
Mehmood W, Shahzad H, Mujtaba MA, Mohsin M, Khan MA, Shamshad GU, et al. Cross population validation of European GWAS-identified risk variants for multiple myeloma in a Pakistani cohort. Hematology, Transfusion and Cell Therapy. 2027;49(1):108585. doi:10.1016/j.htct.2026.108585
BibTeX
@article{Mehmood2027,
author = {Mehmood, Wasif and Shahzad, Hira and Mujtaba, Mariam Ahmed and Mohsin, Muhammad and Khan, Mehreen Ali and Shamshad, Ghassan Umair and Stein, Angelika and Güler, Murat and Raja, Ghazala Kaukab and Macauda, Angelica and Canzian, Federico and Saeed, Sadia},
title = {Cross population validation of European GWAS-identified risk variants for multiple myeloma in a Pakistani cohort},
journal = {Hematology, Transfusion and Cell Therapy},
year = {2027},
volume = {49},
number = {1},
pages = {108585},
doi = {10.1016/j.htct.2026.108585}
}
EUVIMED